Navigation Links
Male contraceptive in trial

Doctors from England are trialling the first long-acting male contraceptive which stops the production of sperm.The drug, which is injected every three months, is a combination of hormones.

In the trial, men are injected with a dose of progesterone, then a pellet of the male hormone testosterone is placed under the skin in the abdomen.Study coordinator Professor David Chater from the Royal Kings Hospital in UK says the technique works by putting the testes to rest, while ensuring the male libido and male characteristics remain intact.//

Professor Chater says he is confident the injections will not impair long-term fertility.Trial participants will receive the injections for up to 18 months, with the trials to be extended to India and China if the results are successful.


'"/>




Page: 1

Related medicine news :

1. Another injectable contraceptive Pill approved by FDA
2. Hormone contraceptives lead to bone problems
3. A new contraceptive
4. A new male contraceptive
5. Spray on contraceptive clears Phase I trial
6. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
7. Lower doses of oral contraceptives helpful in treating acne
8. Dermaseptins: Potent vaginal contraceptives
9. Oral contraceptives safe for women with Lupus erythematosus
10. Islamic Medical Ethics opposes Irreversible contraceptive and surrogate motherhood.
11. The conception of Anya, a period-free contraceptive pill
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: